Taxanes in the Treatment of Advanced Gastric Cancer

被引：16

作者：

Kang, Byung Woog ^{[1
]}

Kwon, Oh-Kyoung ^{[2
]}

Chung, Ho Young ^{[2
]}

Yu, Wansik ^{[2
]}

Kim, Jong Gwang ^{[1
]}

机构：

[1] Kyungpook Natl Univ, Dept Oncol Hematol, Med Ctr, Sch Med,Canc Res Inst, 807 Hogukno, Daegu 41404, South Korea

[2] Kyungpook Natl Univ, Dept Surg, Kyungpook Natl Univ Hosp, Sch Med, Daegu 41494, South Korea

来源：

MOLECULES | 2016年 / 21卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

gastric cancer; taxanes; paclitaxel; docetaxel; chemotherapy; PHASE-III TRIAL; ALBUMIN-BOUND PACLITAXEL; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; PLUS CISPLATIN; ANTITUMOR-ACTIVITY; OPEN-LABEL; FLUOROURACIL; DOCETAXEL; ADENOCARCINOMA;

D O I：

10.3390/molecules21050651

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first-or second-line chemotherapy setting for AGC.

引用

页数：10

共 50 条

[21] Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer
Xiaoting Ma
Yujian Zhang
Cong Wang
Jing Yu
Clinical and Experimental Medicine, 2023, 23 : 381 - 396
[22] Multimodal treatment in locally advanced gastric cancer
Goetze, Oliver Thorsten
Al-Batran, Salah-Eddin
Chevallay, Mickael
Moenig, Stefan Paul
UPDATES IN SURGERY, 2018, 70 (02) : 173 - 179
[23] Taxanes for the Treatment of Metastatic Breast Cancer
Gradishar, W. J.
BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2012, 6 : 159 - 171
[24] Taxanes in the treatment of early breast cancer
Ring, AE
Ellis, PA
CANCER TREATMENT REVIEWS, 2005, 31 (08) : 618 - 627
[25] Adjuvant treatment of breast cancer with taxanes
Wenzel, Catharina
Steger, Guenther G.
BREAST CARE, 2006, 1 (03) : 171 - 175
[26] Nanoparticles for Taxanes Delivery in Cancer Treatment
Wu, ZhouXue
Zheng, Jing
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 16 (07) : 6634 - 6647
[27] Neoadjuvant treatment with taxanes in breast cancer
von Minckwitz, Gunter
BREAST CARE, 2006, 1 (03) : 176 - 184
[28] XLOT regimen instead of FLOT regimen in the primary treatment for patients with locally advanced and metastatic gastric cancer
Isik, Deniz
Koca, Dogan
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S781 - S785
[29] XLOT regimen instead of FLOT regimen in the primary treatment for patients with locally advanced and metastatic gastric cancer
Isik, Deniz
Koca, Dogan
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S781 - S785
[30] What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?
Sohal, Davendra P. S.
Sun, Weijing
EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (12) : 1843 - 1850

← 1 2 3 4 5 →